Integrating Functional Data to Prioritize Causal Variants in Statistical Fine-Mapping Studies

PLoS Genetics

Volumn 10, Issue 10, 2014, Pages

  Kichaev, Gleb ^a   Yang, Wen Yun ^b   Lindstrom, Sara ^c   Hormozdiari, Farhad ^b   Eskin, Eleazar ^a,b,d   Price, Alkes L ^c   Kraft, Peter ^c   Pasaniuc, Bogdan ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; EXON; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LIPID ANALYSIS; NONHUMAN; PROBABILITY; PROCESS OPTIMIZATION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL MODEL; TRANSCRIPTION INITIATION SITE; VALIDATION PROCESS; ALGORITHM; CHROMOSOMAL MAPPING; GENETICS; GENOME-WIDE ASSOCIATION STUDY; PROCEDURES; THEORETICAL MODEL;

ALGORITHMS; CHROMOSOME MAPPING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINKAGE DISEQUILIBRIUM; MODELS, THEORETICAL; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84908324508     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004722     Document Type: Article

References (44)

1. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proceedings of the National Academy of Sciences 106: 9362–9367.
2. Meyer KB, OReilly M, Michailidou K, Carlebur S, Edwards SL, et al. (2013) Fine-scale mapping of the fgfr2 breast cancer risk locus: putative functional variants differentially bind foxa1 and e2f1. The American Journal of Human Genetics 93: 1046–1060.
3. Kote-Jarai Z, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Dadaev T, et al. (2013) Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with tert expression. Human molecular genetics 22: 2520–2528.
4. Wu Y, Waite LL, Jackson AU, Sheu WH, Buyske S, et al. (2013) Trans-ethnic fine-mapping of lipid loci identifies population-specific signals and allelic heterogeneity that increases the trait variance explained. PLoS genetics 9: e1003379.
5. Maller JB, McVean G, Byrnes J, Vukcevic D, Palin K, et al. (2012) Bayesian refinement of association signals for 14 loci in 3 common diseases. Nature genetics 44: 1294–1301.
6. Faye LL, Machiela MJ, Kraft P, Bull SB, Sun L, (2013) Re-ranking sequencing variants in the post-gwas era for accurate causal variant identification. PLoS genetics 9: e1003609.
7. Hormozdiari F, Kostem E, Kang EY, Pasaniuc B, Eskin E (2014) Identifying causal variants at loci with multiple signals of association. Genetics: genetics–114.
8. Type AGEN, Type SA, Consortium DS, Type MA, Consortium DM, et al. (2014) Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nature genetics 46: 234–244.
9. Consortium IMSG, et al. (2013) Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nature genetics.
10. Pickrell JK, (2014) Joint analysis of functional genomic data and genome-wide association studies of 18 human traits. The American Journal of Human Genetics 94: 559–573.
11. Gaffney DJ, Veyrieras JB, Degner JF, Pique-Regi R, Pai AA, et al. (2012) Dissecting the regulatory architecture of gene expression qtls. Genome Biol 13: R7.
12. Zuber V, Silva APD, Strimmer K, (2012) A novel algorithm for simultaneous snp selection in high-dimensional genome-wide association studies. BMC bioinformatics 13: 284.
13. Valdar W, Sabourin J, Nobel A, Holmes CC, (2012) Reprioritizing genetic associations in hit regions using lasso-based resample model averaging. Genetic epidemiology 36: 451–462.
14. Guan Y, Stephens M, et al. (2011) Bayesian variable selection regression for genome-wide association studies and other large-scale problems. The Annals of Applied Statistics 5: 1780–1815.
15. Servin B, Stephens M, (2007) Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS genetics 3: e114.
16. Lee SI, Dudley AM, Drubin D, Silver PA, Krogan NJ, et al. (2009) Learning a prior on regulatory potential from eqtl data. PLoS genetics 5: e1000358.
17. Carbonetto P, Stephens M, (2013) Integrated enrichment analysis of variants and pathways in genome-wide association studies indicates central role for il-2 signaling genes in type 1 diabetes, and cytokine signaling genes in crohn's disease. PLoS genetics 9: e1003770.
18. Consortium EP, et al. (2012) An integrated encyclopedia of dna elements in the human genome. Nature 489: 57–74.
19. Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, et al. (2012) Systematic localization of common disease-associated variation in regulatory dna. Science 337: 1190–1195.
20. Trynka G, Raychaudhuri S, (2013) Using chromatin marks to interpret and localize genetic associations to complex human traits and diseases. Current opinion in genetics & development 23: 635–641.
21. Karczewski KJ, Dudley JT, Kukurba KR, Chen R, Butte AJ, et al. (2013) Systematic functional regulatory assessment of disease-associated variants. Proceedings of the National Academy of Sciences 110: 9607–9612.
22. Trynka G, Sandor C, Han B, Xu H, Stranger BE, et al. (2013) Chromatin marks identify critical cell types for fine mapping complex trait variants. Nature genetics 45: 124–130.
23. Gusev A, Lee SH, Neale BM, Trynka G, Vilhjalmsson BJ, et al. (2014) Regulatory variants explain much more heritability than coding variants across 11 common diseases. bioRxiv.
24. Udler MS, Meyer KB, Pooley KA, Karlins E, Struewing JP, et al. (2009) Fgfr2 variants and breast cancer risk: fine-scale mapping using african american studies and analysis of chromatin conformation. Human molecular genetics 18: 1692–1703.
25. Trynka G, Hunt KA, Bockett NA, Romanos J, Mistry V, et al. (2011) Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nature genetics 43: 1193–1201.
26. Patsopoulos NA, Barcellos LF, Hintzen RQ, Schaefer C, van Duijn CM, et al. (2013) Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: Hla and non-hla effects. PLoS genetics 9: e1003926.
27. Liu JZ, Almarri MA, Gaffney DJ, Mells GF, Jostins L, et al. (2012) Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nature genetics 44: 1137–1141.
28. Fellay J, Thompson AJ, Ge D, Gumbs CE, Urban TJ, et al. (2010) Itpa gene variants protect against anaemia in patients treated for chronic hepatitis c. Nature 464: 405–408.
29. Lewinger JP, Conti DV, Baurley JW, Triche TJ, Thomas DC, (2007) Hierarchical bayes prioritization of marker associations from a genome-wide association scan for further investigation. Genetic epidemiology 31: 871–882.
30. Quintana M, Conti D, (2013) Integrative variable selection via bayesian model uncertainty. Statistics in medicine 32: 4938–4953.
31. Udler MS, Tyrer J, Easton DF, (2010) Evaluating the power to discriminate between highly correlated snps in genetic association studies. Genetic epidemiology 34: 463–468.
32. Carlin BP, Louis TA (2000) Bayes and empirical Bayes methods for data analysis. CRC Press.
33. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466: 707–713.
34. Pasaniuc B, Zaitlen N, Shi H, Bhatia G, Gusev A, et al. (2014) Fast and accurate imputation of summary statistics enhances evidence of functional enrichment. Bioinformatics: btu416.
35. Han B, Kang HM, Eskin E, (2009) Rapid and accurate multiple testing correction and power estimation for millions of correlated markers. PLoS genetics 5: e1000456.
36. Conneely KN, Boehnke M, (2007) So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests. American journal of human genetics 81: 1158–1168.
37. Zaitlen N, Pasaniuc B, Gur T, Ziv E, Halperin E, (2010) Leveraging genetic variability across populations for the identification of causal variants. American journal of human genetics 86: 23–33.
38. Liu DC, Nocedal J, (1989) On the limited memory bfgs method for large scale optimization. Mathematical programming 45: 503–528.
39. Johnson SG (2010) The nlopt nonlinear-optimization package.
40. Su Z, Marchini J, Donnelly P (2011) Hapgen2: simulation of multiple disease snps. Bioinformatics.
41. Yang J, Ferreira T, Morris AP, Medland SE, Madden PA, et al. (2012) Conditional and joint multiple-snp analysis of gwas summary statistics identifies additional variants influencing complex traits. Nature genetics 44: 369–375.
42. Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, et al. (2012) The accessible chromatin landscape of the human genome. Nature 489: 75–82.
43. Teslovich et al TM, (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466: 707–713.
44. Shifman S, Kuypers J, Kokoris M, Yakir B, Darvasi A, (2003) Linkage disequilibrium patterns of the human genome across populations. Human molecular genetics 12: 771–776.